Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Sell
1,980
-3,508
-64% -$1.2M 0.04% 388
2026
Q1
$1.93M Buy
5,488
+717
+15% +$256K 0.1% 192
2025
Q4
$1.56M Buy
+4,771
New +$1.51M 0.09% 203

Other funds holding AMGN

Evolve Private Wealth's AMGN Position: Q2 2026 in Review

Evolve Private Wealth reduced its Amgen (AMGN) stake by 64% in Q2 2026, selling an estimated $1.2M and leaving 1,980 shares worth $717K. The position accounts for 0.04% of the portfolio, ranked #388.

Evolve Private Wealth first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.93M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Evolve Private Wealth held 1,980 shares of Amgen worth $717K as of Q2 2026.
  • Evolve Private Wealth sold 3,508 Amgen shares in Q2 2026, an estimated $1.2M.
  • Amgen made up 0.04% of Evolve Private Wealth's portfolio in Q2 2026, its #388 holding.
  • Evolve Private Wealth first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Amgen position peaked at $1.93M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.